Corrigendum to "Probiotic mixture VSL#3: An overview of basic and clinical studies in chronic diseases".

[This corrects the article on p. 1361 in vol. 8, PMID: 32368530.]. ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.

Core Tip: This manuscript is to further explain VSL#3 mentioned in it for probiotic mixture VSL#3: An overview of basic and clinical studies in chronic diseases (World J Clin Cases 2020; 8: 1361-1384).

CORRECTION

Correction to: Cheng FS, Pan D, Chang B, Jiang M, Sang LX. Probiotic mixture VSL#3: An overview of basic and clinical studies in chronic diseases. World J Clin Cases 2020; 8: 1361-1384 PMID: 32368530 DOI: 10.12998/wjcc.v8.i8.1361.

We are the team of Min Jiang and Li-Xuan Sang from the First Affiliated Hospital, China Medical University. We published an article about probiotic mixture VSL#3 on April 26, 2020. Now we solemnly declare that the studies mentioned in this article[1] evaluated the probiotic formulation known as VSL#3 before January 31, 2016. The probiotic formulation is now commonly referred to as De Simone Formulation. In addition, the product currently known as VSL#3 is not the same as De Simone Formulation. De Simone Formulation is now available as Visbiome in the United States and Vivomixx in Europe.